Jardiamet 12.5 mg/1000 mg TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: empagliflozin + metformin, metformin, empagliflozin
Brand name
(ARTG)
: JARDIAMET 12.5 mg / 1000 mg empagliflozin/metformin hydrochloride 12.5mg/1000mg film coated tablet blister packDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
JARDIAMET is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus when treatment with both empagliflozin and metformin is appropriate (see Sections 4.2 Dose and method of administration and 5.1 Pharmacodynamic properties - Clinical trials).,Empagliflozin is indicated in adults with type 2 diabetes mellitus and established cardiovascular disease to reduce the risk of cardiovascular death (see Section 5.1 Pharmacodynamic properties - Clinical trials).,To prevent cardiovascular deaths, empagliflozin should be used in conjunction with other measures to reduce cardiovascular risk in line with the current standard of care.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Tablet, film coated
- Oral
- Dark brownish purple, oval, biconvex film-coated tablets. One side is debossed with BI company symbol and "S12", the other side is debossed with "1000".
Storage conditions
(ARTG)
- Store below 30 degrees Celsius
- Shelf lifetime is 3 Years.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 14 pack
- 60 pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient empagliflozin + metformin
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
For the active ingredient empagliflozin
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems